{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:15:33Z","timestamp":1763662533377},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1991,4,1]],"date-time":"1991-04-01T00:00:00Z","timestamp":670464000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol. Infect. Dis."],"published-print":{"date-parts":[[1991,4]]},"DOI":"10.1007\/bf01967001","type":"journal-article","created":{"date-parts":[[2005,7,30]],"date-time":"2005-07-30T07:43:34Z","timestamp":1122709414000},"page":"275-290","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of quinolones in experimental animal models of infections"],"prefix":"10.1007","volume":"10","author":[{"given":"W. M.","family":"Scheld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01967001_CR1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-0028-1129486","volume":"61","author":"G Domagk","year":"1935","unstructured":"Domagk G Ein Beitrag zur Chemotherapie der bakteriellen Infektionen. Deutsche Medizinische Wochenschrift 1935, 61: 250\u2013253.","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"BF01967001_CR2","first-page":"1","volume-title":"Experimental models in antimicrobial chemotherapy. Volume 1","author":"O Zak","year":"1986","unstructured":"Zak O, Sande MA Introduction: the role of animal models in the evaluation of new antibiotics. In: Zak O, Sande MA (ed): Experimental models in antimicrobial chemotherapy. Volume 1. Academic Press, London, 1986, p. 1\u20135."},{"key":"BF01967001_CR3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/BF01975159","volume":"36","author":"O Zak","year":"1980","unstructured":"Zak O Scope and limitations of experimental chemotherapy. Experientia 1980, 36: 479\u2013483.","journal-title":"Experientia"},{"issue":"Supplement","key":"BF01967001_CR4","first-page":"109","volume":"14","author":"M Barza","year":"1978","unstructured":"Barza M A critique of animal models in antibiotic research. Scandinavian Journal of Infectious Disease 1978, 14, Supplement: 109\u2013117.","journal-title":"Scandinavian Journal of Infectious Disease"},{"issue":"Supplement","key":"BF01967001_CR5","first-page":"189","volume":"14","author":"MG Bergeron","year":"1978","unstructured":"Bergeron MG A review of models for the therapy of experimental infections. Scandinavian Journal of Infectious Disease 1978, 14, Supplement: 189\u2013206.","journal-title":"Scandinavian Journal of Infectious Disease"},{"key":"BF01967001_CR6","first-page":"280","volume":"32","author":"DG Harter","year":"1960","unstructured":"Harter DG, Petersdorf RG A consideration of the pathogenesis of bacterial meningitis: review of experimental and clinical studies. Yale Journal of Biology and Medicine 1960, 32: 280\u2013309.","journal-title":"Yale Journal of Biology and Medicine"},{"issue":"Supplement 1","key":"BF01967001_CR7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0163-4453(81)80003-5","volume":"3","author":"WM Scheld","year":"1981","unstructured":"Scheld WM Pathophysiological correlates in bacterial meningitis. Journal of Infection 1981, 3, Supplement 1: 5\u201319.","journal-title":"Journal of Infection"},{"key":"BF01967001_CR8","first-page":"139","volume-title":"Experimental animal models in antimicrobial chemotherapy. Volume 1","author":"WM Scheld","year":"1986","unstructured":"Scheld WM Experimental animal models of bacterial meningitis. In: Zak O, Sande MA (ed): Experimental animal models in antimicrobial chemotherapy. Volume 1. Academic Press, London, 1986, p. 139\u2013186."},{"issue":"Supplement 4A","key":"BF01967001_CR9","first-page":"67","volume":"82","author":"VT Andriole","year":"1987","unstructured":"Andriole VT Efficacy of ciprofloxacin in animal models of infection. American Journal of Medicine 1987, 82, Supplement 4A: 67\u201370.","journal-title":"American Journal of Medicine"},{"key":"BF01967001_CR10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/clinids\/10.Supplement_1.S113","volume":"10","author":"MA Sande","year":"1988","unstructured":"Sande MA, Brooks-Fournier RA, Gerberding JL Use of animal models in evaluation of the quinolones. Reviews of Infectious Diseases 1988, 10: 113\u2013116.","journal-title":"Reviews of Infectious Diseases"},{"issue":"Supplement 5A","key":"BF01967001_CR11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0002-9343(89)90016-8","volume":"87","author":"VT Andriole","year":"1989","unstructured":"Andriole VT An update on the efficacy of ciprofloxacin in animal models of infection. American Journal of Medicine 1989, 87, Supplement 5A: 32\u201334.","journal-title":"American Journal of Medicine"},{"issue":"Supplement 5","key":"BF01967001_CR12","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/clinids\/11.Supplement_5.S1194","volume":"11","author":"WM Scheld","year":"1989","unstructured":"Scheld WM Quinolone therapy for infections of the central nervous system. Reviews of Infectious Diseases 1989, 11, Supplement 5: 1194\u20131202.","journal-title":"Reviews of Infectious Diseases"},{"issue":"Supplement 4A","key":"BF01967001_CR13","first-page":"63","volume":"82","author":"MA Sande","year":"1987","unstructured":"Sande MA, Brooks-Fournier RA, Gerberding JL Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia. American Journal of Medicine 1987, 82, Supplement 4A: 63\u201366.","journal-title":"American Journal of Medicine"},{"key":"BF01967001_CR14","first-page":"110\/23","volume":"5","author":"M Armengaud","year":"1983","unstructured":"Armengaud M, Tran VT, DiConstanzo B Study of pefloxacin diffusion into serum and CSF in the dog, both with healthy meninges and during experimental meningitis. Spitzy KH, Karrer K (ed): Proceedings of the 13th International Congress of Chemotherapy. Vienna, 1983, 5: 110\/23\u2013110\/28.","journal-title":"Vienna"},{"issue":"Supplement C","key":"BF01967001_CR15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jac\/14.suppl_C.57","volume":"14","author":"TV Tho","year":"1984","unstructured":"Tho TV, Armengaud A, Dauet B Diffusion of enoxacin into the cerebrospinal fluid in dogs with healthy meninges and with experimental meningitis. Journal of Antimicrobial Chemotherapy 1984, 14, Supplement C: 57\u201362.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01967001_CR16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1128\/AAC.25.4.463","volume":"25","author":"G Montay","year":"1984","unstructured":"Montay G, Goueffon Y, Roquet F Absorption, distribution, metabolic rate, and climination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans. Antimicrobial Agents and Chemotherapy 1984, 25: 463\u2013472.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/AAC.29.3.409","volume":"29","author":"AM Shibl","year":"1986","unstructured":"Shibl AM, Hackbarth CJ, Sande MA Evaluation of pefloxacin in experimentalEscherichia coli meningitis. Antimicrobial Agents and Chemotherapy 1986, 29: 409\u2013411.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"Supplement D","key":"BF01967001_CR18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/jac\/18.Supplement_D.65","volume":"18","author":"CJ Hackbarth","year":"1986","unstructured":"Hackbarth CJ, Chambers HF, Stella F, Shibl AM, Sande MA Ciprofloxacin in experimentalPseudomonas aeruginosa meningitis in rabbits. Journal of Antimicrobial Chemotherapy 1986, 18, Supplement D: 65\u201369.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"Supplement 5","key":"BF01967001_CR19","first-page":"1208","volume":"11","author":"JM Decazes","year":"1989","unstructured":"Decazes JM, Mohler J, Bure A, Vallois JM, Meulemans A, Modai J Pharmacokinetics of fleroxacin and its metabolites in serum, cerebrospinal fluid, and brain of rabbits with and without experimentalEscherichia coli meningitis. Reviews of Infectious Diseases 1989, 11, Supplement 5: 1208\u20131209.","journal-title":"Reviews of Infectious Diseases"},{"issue":"Supplement 5A","key":"BF01967001_CR20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0002-9343(89)90071-5","volume":"87","author":"S Schonwald","year":"1989","unstructured":"Schonwald S, Beus I, Lisic' M, Car V, Gmajnicki B Ciprofloxacin in the treatment of gram-negative bacillary meningitis. American Journal of Medicine 1989, 87, Supplement 5A: 248\u2013249.","journal-title":"American Journal of Medicine"},{"key":"BF01967001_CR21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1128\/AAC.27.5.685","volume":"27","author":"PM Sullam","year":"1985","unstructured":"Sullam PM, Ta\u00fcber MG, Hackbarth CJ, Chambers HF, Scott KG, Sande MA Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains ofStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1985, 27: 685\u2013687.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1128\/AAC.29.3.461","volume":"29","author":"M Gilbert","year":"1986","unstructured":"Gilbert M, Boscia JA, Kobasa WD, Kaye D Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistantStaphylococcus aureus endocarditis. Antimicrobial Agents and Chemotherapy 1986, 29: 461\u2013463.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/AAC.30.3.382","volume":"30","author":"TC Carpenter","year":"1986","unstructured":"Carpenter TC, Hackbarth CJ, Chambers HF, Sande MA Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains ofStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1986, 30: 382\u2013384.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1128\/AAC.31.4.527","volume":"31","author":"GW Kaatz","year":"1987","unstructured":"Kaatz GW, Barriere SL, Schaberg DR, Fekety R Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistantStaphylococcus aureus endocarditis. Antimicrobial Agents and Chemotherapy 1987, 31: 527\u2013530.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jac\/20.5.753","volume":"20","author":"GW Kaatz","year":"1987","unstructured":"Kaatz GW, Barriere SL, Schaberg DR, Fekety R The emergence of resistance to ciprofloxacin during treatment of experimentalStaphylococcus aureus endocarditis. Journal of Antimicrobial Chemotherapy 1987, 20: 753\u2013758.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01967001_CR26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/AAC.31.4.539","volume":"31","author":"CM Perrone","year":"1987","unstructured":"Perrone CM, Malinverni R, Glauser MP Treatment ofStaphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination. Antimicrobial Agents and Chemotherapy 1987, 31: 539\u2013543.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/AAC.32.2.262","volume":"32","author":"JA Boscia","year":"1988","unstructured":"Boscia JA, Kobasa WD, Kaye D Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimentalStaphylococcus aureus endocarditis. Antimicrobial Agents and Chemotherapy 1988, 32: 262\u2013264.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/AAC.32.5.747","volume":"32","author":"M Fernanedez-Guerrero","year":"1988","unstructured":"Fernanedez-Guerrero M, Rouse M, Henry N, Wilson W Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1988, 32: 747\u2013751.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR29","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/AAC.32.6.919","volume":"32","author":"C Thauvin","year":"1988","unstructured":"Thauvin C, Lemeland JF, Humbert G, Fillastre JP Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1988, 32: 919\u2013921.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1128\/AAC.33.4.519","volume":"33","author":"GW Kaatz","year":"1989","unstructured":"Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ Efficacy of fleroxacin in experimental methicillin-resistantStaphylococcus aureus endocarditis. Antimicrobial Agents and Chemotherapy 1989, 33: 519\u2013521.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR31","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1128\/AAC.33.8.1184","volume":"33","author":"GW Kaatz","year":"1989","unstructured":"Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ Ciprofloxacin and rifampin, alone and in combination, for therapy of experimentalStaphylococcus aureus endocarditis. Antimicrobial Agents and Chemotherapy 1989, 33: 1184\u20131187.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/AAC.34.2.257","volume":"34","author":"GW Kaatz","year":"1990","unstructured":"Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ Efficacy of ofloxacin in experimentalStaphylococcus aureus endocarditis. Antimicrobial Agents and Chemotherapy 1990, 34: 257\u2013260.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR33","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1128\/AAC.34.6.1143","volume":"34","author":"MT Hessen","year":"1990","unstructured":"Hessen MT, Pitsakis PG, Kaye D Oral temafloxacin versus vancomycin for therapy of experimental endocarditis caused by methicillin-resistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1990, 34: 1143\u20131145.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1128\/AAC.34.2.273","volume":"34","author":"MS Rouse","year":"1990","unstructured":"Rouse MS, Wilcox RM, Henry NK, Steckelberg JM, Wilson WR Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistantStaphylococcus epidermidis. Antimicrobial Agents and Chemotherapy 1990, 34: 273\u2013276.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR35","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/AAC.31.3.430","volume":"31","author":"M Fernandez-Guerrero","year":"1987","unstructured":"Fernandez-Guerrero M, Rouse MS, Henry NK, Geraci JE, Wilson WR In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis. Antimicrobial Agents and Chemotherapy 1987, 31: 430\u2013433.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"Supplement 5","key":"BF01967001_CR36","first-page":"1210","volume":"11","author":"GM Eliopoulos","year":"1989","unstructured":"Eliopoulos GM, Willey S, Murray BE, Moellering RG Ciprofloxacin in experimental endocarditis due to a \u03b2-lactamase-producing, highly gentamicin-resistant strain ofEnterococcus faecalis. Reviews of Infectious Diseases 1989, 11, Supplement 5: 1210\u20131211.","journal-title":"Reviews of Infectious Diseases"},{"key":"BF01967001_CR37","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1128\/AAC.27.5.708","volume":"27","author":"JA Boscia","year":"1985","unstructured":"Boscia JA, Kobasa WD, Kaye D Enoxacin compared with cefoperazone for the treatment of experimentalEnterobacter aerogenes endocarditis. Antimicrobial Agents and Chemotherapy 1985, 27: 708\u2013711.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR38","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1128\/AAC.28.3.428","volume":"28","author":"RW Strunk","year":"1985","unstructured":"Strunk RW, Gratz JC, Maserati R, Scheld WM Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimentalPseudomonas aeruginosa endocarditis. Antimicrobial Agents and Chemotherapy 1985, 28: 428\u2013432.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR39","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/infdis\/153.4.707","volume":"153","author":"MJ Ingerman","year":"1986","unstructured":"Ingerman MJ, Pitsakis PG, Rosenberg AF, Levison ME The importance of pharmacodynamics in determining the dosage interval in therapy for experimentalPseudomonas endocarditis in the rat. Journal of Infectious Diseases 1986, 153: 707\u2013714.","journal-title":"Journal of Infectious Diseases"},{"key":"BF01967001_CR40","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1128\/AAC.30.4.528","volume":"30","author":"AS Bayer","year":"1986","unstructured":"Bayer AS, Lindsay P, Yih J, Hirano L, Lee D, Blomquist IK Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply \u03b2-lactam-resistant variant ofPseudomonas aeruginosa stably derepressed for \u03b2-lactamase production. Antimicrobial Agents and Chemotherapy 1986, 30: 528\u2013531.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR41","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000238436","volume":"32","author":"AS Bayer","year":"1986","unstructured":"Bayer AS, Kim KS In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due toPseudomonas aeruginosa. Chemotherapy 1986, 32: 364\u2013373.","journal-title":"Chemotherapy"},{"key":"BF01967001_CR42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/AAC.32.2.231","volume":"32","author":"AS Bayer","year":"1988","unstructured":"Bayer AS, Hirano L, Yih J Development of \u03b2-lactam resistance and increased quinolone MICs during therapy of experimentalPseudomonas aeruginosa endocarditis. Antimicrobial Agents and Chemotherapy 1988,32: 231\u2013235.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR43","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(89)91083-0","volume":"ii","author":"RJ Dworkin","year":"1989","unstructured":"Dworkin RJ, Lee BL, Sande MA, Chambers HF Treatment of right-sidedStaphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet 1989, ii: 1071\u20131073.","journal-title":"Lancet"},{"key":"BF01967001_CR44","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/infdis\/155.6.1226","volume":"155","author":"M Ingerman","year":"1987","unstructured":"Ingerman M, Pitsakis PG, Rosenberg A, Hessen MT, Abrutyn E, Murray BE, Levison ME Beta-lactamase production in experimental endocarditis due to aminoglycoside-resistantStreptococcus faecalis. Journal of Infectious Disease 1987, 155: 1226\u20131232.","journal-title":"Journal of Infectious Disease"},{"key":"BF01967001_CR45","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/jac\/17.5.641","volume":"17","author":"AS Bayer","year":"1986","unstructured":"Bayer AS, Blomquist IK, Kim KS Ciprofloxacin in experimental aortic valve endocarditis due toPseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 1986, 17: 641\u2013649.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01967001_CR46","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1128\/AAC.33.5.624","volume":"33","author":"S Chamberland","year":"1989","unstructured":"Chamberland S, Bayer AS, Schollardt T, Wong SA, Bryan LE Characterization of mechanisms of quinolone resistance inPseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis. Antimicrobial Agents and Chemotherapy 1989, 33: 624\u2013634.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR47","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0002-9343(88)90122-2","volume":"84","author":"GL Daikos","year":"1988","unstructured":"Daikos GL, Kathpalia SB, Lolans VT, Jackson GG, Fosslein E Longterm oral ciprofloxacin: experience in the treatment of incurable infective endocarditis. American Journal of Medicine 1988, 84: 786\u2013790.","journal-title":"American Journal of Medicine"},{"key":"BF01967001_CR48","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/clinids\/10.1.103","volume":"10","author":"CW Norden","year":"1988","unstructured":"Norden CW Lessons learned from animal models of osteomyclitis. Reviews of Infectious Diseases 1988, 10: 103\u2013110.","journal-title":"Reviews of Infectious Diseases"},{"key":"BF01967001_CR49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/AAC.31.2.259","volume":"31","author":"JT Mader","year":"1987","unstructured":"Mader JT, Morrison LT, Adams KR Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimentalStaphylococcus aureus osteomyelitis. Antimicrobial Agents and Chemotherapy 1987, 31: 259\u2013263.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR50","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/infdis\/153.5.956","volume":"153","author":"CW Norden","year":"1986","unstructured":"Norden CW, Shinners E, Niederreiter K Clindamycin treatment of experimental chronic osteomyelitis due toStaphylococcus aureus. Journal of Infectious Diseases 1986, 153: 956\u2013959.","journal-title":"Journal of Infectious Diseases"},{"key":"BF01967001_CR51","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1128\/AAC.33.10.1760","volume":"33","author":"JT Mader","year":"1989","unstructured":"Mader JT, Adams K, Morrison L Comparative evaluation of cefazolin and clindamycin in the treatment of experimentalStaphylococcus aureus osteomyelitis in rabbits. Antimicrobial Agents and Chemotherapy 1989, 33: 1760\u20131764.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR52","first-page":"973","volume-title":"Current chemotherapy and immunotherapy","author":"O Zak","year":"1982","unstructured":"Zak O, Zak F, Rich R, Tosch W, Kradolfer F, Scheld WM Experimental staphylococcal osteomyelitis in rats. In: Periti P, Grassi GG (ed): Current chemotherapy and immunotherapy. American Society for Microbiology, Washington, DC, 1982, p. 973\u2013974."},{"issue":"Supplement 4A","key":"BF01967001_CR53","first-page":"73","volume":"82","author":"NK Henry","year":"1987","unstructured":"Henry NK, Rouse MS, Whitesell AL, McConnell ME, Wilson WR Treatment of methicillin-resistantStaphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin. American Journal of Medicine 1987, 82, Supplement 4A: 73\u201375.","journal-title":"American Journal of Medicine"},{"key":"BF01967001_CR54","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/AAC.33.5.689","volume":"33","author":"JT Mader","year":"1989","unstructured":"Mader JT, Adams K Comparative evaluation of daptomycin (LY 146032) and vancomycin in the treatment of experimental methicillin-resistantStaphylococcus aureus osteomyelitis in rabbits. Antimicrobial Agents and Chemotherapy 1989, 33: 689\u2013692.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR55","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1128\/AAC.34.6.1014","volume":"34","author":"R Dworkin","year":"1990","unstructured":"Dworkin R, Modin G, Kunz S, Rich R, Zak O, Sande M Comparative efficacies of ciprofloxacin, pefloxacin and vancomycin in combination with rifampin in a rat model of methicillin-resistantStaphylococcus aureus chronic osteomyelitis. Antimicrobial Agents and Chemotherapy 1990, 34: 1014\u20131016.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR56","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/infdis\/151.2.291","volume":"151","author":"CW Norden","year":"1985","unstructured":"Norden CW, Shinners E Ciprofloxacin as therapy for experimental osteomyelitis caused byPseudomonas aeruginosa. Journal of Infectious Diseases 1985, 151: 291\u2013294.","journal-title":"Journal of Infectious Diseases"},{"key":"BF01967001_CR57","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/infdis\/155.4.823","volume":"155","author":"CW Norden","year":"1987","unstructured":"Norden CW, Niederreiter K Ofloxacin therapy for experimental osteomyelitis caused byPseudomonas aeruginosa. Journal of Infectious Diseases 1987, 155: 823\u2013824.","journal-title":"Journal of Infectious Diseases"},{"issue":"Supplement 5","key":"BF01967001_CR58","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/clinids\/11.Supplement_5.S1259","volume":"11","author":"FA Waldvogel","year":"1989","unstructured":"Waldvogel FA Use of quinolones for the treatment of osteomyelitis and septic arthritis. Reviews of Infectious Diseases 1989, 11, Supplement 5: 1259\u20131263.","journal-title":"Reviews of Infectious Diseases"},{"key":"BF01967001_CR59","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/BF01975177","volume":"8","author":"AS Bayer","year":"1989","unstructured":"Bayer AS Clinical utility of new quinolones in treatment of osteomyelitis and lower respiratory tract infections. European Journal of Clinical Microbiology and Infectious Disease 1989, 8: 1102\u20131110.","journal-title":"European Journal of Clinical Microbiology and Infectious Disease"},{"issue":"Supplement 5","key":"BF01967001_CR60","first-page":"1271","volume":"11","author":"DR Snydman","year":"1989","unstructured":"Snydman DR, Barza M, McGowan K, Kaplan K, Cuchural GC, Gill M, Daly J Randomized comparative trial of ciprofloxacin for treatment of patients with osteomyelitis. Reviews of Infectious Diseases 1989, 11, Supplement 5: 1271\u20131272.","journal-title":"Reviews of Infectious Diseases"},{"key":"BF01967001_CR61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/AAC.34.1.40","volume":"34","author":"LO Gentry","year":"1990","unstructured":"Gentry LO, Rodriquez GG Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis. Antimicrobial Agents and Chemotherapy 1990, 34: 40\u201343.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR62","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/AAC.34.5.849","volume":"34","author":"M Dan","year":"1990","unstructured":"Dan M, Siegman-Igra Y, Pitlik S, Raz R Oral ciprofloxacin treatment ofPseudomonas aeruginosa osteomyelitis. Antimicrobial Agents and Chemotherapy 1990, 34: 849\u2013852.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0732-8893(90)90103-3","volume":"13","author":"B Wispelwey","year":"1990","unstructured":"Wispelwey B, Scheld WM Ciprofloxacin in the treatment ofStaphylococcus aureus osteomyelitis: a review. Diagnostic Microbiology and Infectious Diseases 1990, 13: 169\u2013171.","journal-title":"Diagnostic Microbiology and Infectious Diseases"},{"key":"BF01967001_CR64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3928\/0147-7447-19900101-10","volume":"13","author":"RR MacGregor","year":"1990","unstructured":"MacGregor RR, Graziani AL, Esterhai JL Oral ciprofloxacin for osteomyelitis. Orthopedics 1990, 13: 55\u201360.","journal-title":"Orthopedics"},{"key":"BF01967001_CR65","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/jac\/20.1.77","volume":"20","author":"B Kemmerich","year":"1987","unstructured":"Kemmerich B, Borner K, Pennington JE Comparative efficacies of ciprofloxacin, ampicillin and chloramphenicol in treatment of experimentalHaemophilus influenzae pneumonia. Journal of Antimicrobial Chemotherapy 1987, 20: 77\u201383.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01967001_CR66","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/AAC.31.3.417","volume":"31","author":"B Kemmerich","year":"1987","unstructured":"Kemmerich B, Borner K, Pennington JE Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimentalHaemophilus influenzae pneumonia. Antimicrobial Agents and Chemotherapy 1987, 31: 417\u2013420.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR67","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1128\/AAC.31.11.1809","volume":"31","author":"R Rossendaal","year":"1987","unstructured":"Rossendaal R, Bakker-Woudenberg IAJM, van den Berghe-van Raffe M, Vink-van der Berg JC, Michel MF Comparative activities of ciprofloxacin and ceftazidime againstKlebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats. Antimicrobial Agents and Chemotherapy 1987, 31: 1809\u20131815.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR68","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1128\/AAC.33.8.1144","volume":"33","author":"M Asahara","year":"1989","unstructured":"Asahara M, Tsuji A, Goto S, Masuda K, Kiuchi A In vitro and in vivo activities of QA-241, a new tricyclic quinolone derivative. Antimicrobial Agents and Chemotherapy 1989, 33: 1144\u20131152.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.28.1.15","volume":"28","author":"A Saito","year":"1985","unstructured":"Saito A, Sawatari K, Fukuda Y, Nagasawa M, Koga H, Tomonaga A, Nakazato H, Fujita K, Shigeno Y, Suzuyama Y, Yamaguchi K, Isumikawa K, Hara K Susceptibility ofLegionella pneumophila to ofloxacin in vitro and in experimentalLegionella pneumonia in guinea pigs. Antimicrobial Agents and Chemotherapy 1985, 28: 15\u201320.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR70","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1128\/AAC.32.9.1427","volume":"32","author":"S Kohno","year":"1988","unstructured":"Kohno S, Yamaguchi K, Dohtsu Y, Koga H, Hayashi T, Hirota M, Saito A, Hara K Efficacy of NY-918 against experimental Legionnaire's disease. Antimicrobial Agents and Chemotherapy 1988, 32: 1427\u20131429.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"Supplement B","key":"BF01967001_CR71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jac\/17.suppl_B.41","volume":"17","author":"E Dournon","year":"1986","unstructured":"Dournon E, Rajagopalan P, Vilde JL, Pocidalo JJ Efficacy of pefloxacin in comparison with erythromycin in the treatment of experimental guinea pig legionellosis. Journal of Antimicrobial Chemotherapy 1986, 17, Supplement B: 41\u201348.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01967001_CR72","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/jac\/20.6.875","volume":"20","author":"D Havlichek","year":"1987","unstructured":"Havlichek D, Pohlod D, Saravolatz L Comparison of ciprofloxacin and rifampicin in experimentalLegionella pneumophila pneumonia. Journal of Antimicrobial Chemotherapy 1987, 20: 875\u2013881.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01967001_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.26.1.1","volume":"26","author":"JB Schiff","year":"1984","unstructured":"Schiff JB, Small GL, Pennington JE Comparative activities of ciprofloxacin, ticarcillin and tobramycin againstPseudomonas aeruginosa pneumonia. Antimicrobial Agents and Chemotherapy 1984, 26: 1\u20134.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR74","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1128\/AAC.29.3.395","volume":"29","author":"B Kemmerich","year":"1986","unstructured":"Kemmerich B, Small GJ, Pennington JE Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimentalPseudomonas pneumonia. Antimicrobial Agents and Chemotherapy 1986, 29: 395\u2013399.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR75","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1128\/AAC.27.4.452","volume":"27","author":"FM Gordin","year":"1985","unstructured":"Gordin FM, Hackbarth CJ, Scott RG, Sande MA Activities of pefloxacin and ciprofloxacin in experimentally inducedPseudomonas pneumonia in neutropenic guinea pigs. Antimicrobial Agents and Chemotherapy 1985, 27: 452\u2013454.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR76","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/infdis\/149.6.980","volume":"149","author":"MG Rusnak","year":"1984","unstructured":"Rusnak MG, Drake TA, Hackbarth CJ, Sande MA Single versus combination antibiotic therapy for pneumonia due toPseudomonas aeruginosa in neutropenic guinea pigs. Journal of Infectious Diseases 1984, 149: 980\u2013985.","journal-title":"Journal of Infectious Diseases"},{"key":"BF01967001_CR77","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/AAC.31.3.398","volume":"31","author":"FM Gordin","year":"1987","unstructured":"Gordin FM, Rusnak MG, Sande MA Evaluation of combination chemotherapy in a lightly anesthetized animal model ofPseudomonas pneumonia. Antimicrobial Agents and Chemotherapy 1987, 31: 398\u2013403.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF01967001_CR78","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000417619","volume":"42","author":"MS Collins","year":"1989","unstructured":"Collins MS, Edwards A, Roby RE, Mehton NS, Ladehoff D Pseudomonas immune globulin therapy improves survival in experimentalPseudomonas aeruginosa bacteremic pneumonia. Antibiotics and Chemotherapy 1989, 42: 184\u2013192.","journal-title":"Antibiotics and Chemotherapy"},{"key":"BF01967001_CR79","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/infdis\/159.6.1073","volume":"159","author":"HH Collins","year":"1989","unstructured":"Collins HH, Cross AS, Dobek A, Opal SM, McClain JB, Sadoff JC Oral ciprofloxacin and a monoclonal antibody to lipopolysaccharide protect leukopenic rats from lethal infection withPseudomonas aeruginosa. Journal of Infectious Diseases 1989, 159: 1073\u20131082.","journal-title":"Journal of Infectious Diseases"},{"key":"BF01967001_CR80","first-page":"839","volume":"23","author":"MA Smythe","year":"1989","unstructured":"Smythe MA, Rybak MJ Ofloxacin: a review. Drug Intelligence and Clinical Pharmacy 1989, 23: 839\u2013846.","journal-title":"Drug Intelligence and Clinical Pharmacy"},{"issue":"Supplement 5","key":"BF01967001_CR81","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/clinids\/11.Supplement_5.S1212","volume":"11","author":"JP Thys","year":"1989","unstructured":"Thys JP, Jacobs F, Motte S Quinolones in the treatment of lower respiratory tract infections. Reviews of Infectious Diseases 1989, 11, Supplement 5: 1212\u20131219.","journal-title":"Reviews of Infectious Diseases"},{"key":"BF01967001_CR82","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/jac\/21.6.795","volume":"21","author":"C Martin","year":"1988","unstructured":"Martin C, Govin F, Fourrier F, Junginger W, Prieur BL Pefloxacin in the treatment of nosocomial lower respiratory tract infections in intensive care patients. Journal of Antimicrobial Chemotherapy 1988, 21: 795\u2013799.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01967001_CR83","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/archinte.1989.00390100083020","volume":"149","author":"CA Peloquin","year":"1989","unstructured":"Peloquin CA, Cumbo TJ, Nix DE, Sands MF, Schentag JJ Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Archives of Internal Medicine 1989, 149: 2269\u20132273.","journal-title":"Archives of Internal Medicine"},{"key":"BF01967001_CR84","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0002-9343(89)80838-1","volume":"87","author":"B Cooper","year":"1989","unstructured":"Cooper B, Lawlor M Pneumococcal bacteremia during ciprofloxacin therapy for pneumococcal pneumonia. American Journal of Medicine 1989, 87: 475.","journal-title":"American Journal of Medicine"},{"issue":"Supplement 6C","key":"BF01967001_CR85","first-page":"6C-52S","volume":"87","author":"JM Stocks","year":"1989","unstructured":"Stocks JM, Wallace RJ, Griffith DE, Garcia JG, Kohler RB Ofloxacin in community-acquired lower respiratory infections. American Journal of Medicine 1989, 87, Supplement 6C: 6C-52S\u20136C-56S.","journal-title":"American Journal of Medicine"},{"key":"BF01967001_CR86","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/clinids\/11.6.878","volume":"11","author":"SM Douidar","year":"1989","unstructured":"Douidar SM, Snodgrass WR Potential role of fluoroquinolones in pediatric infections. Reviews of Infectious Diseases 1989, 11: 878\u2013889.","journal-title":"Reviews of Infectious Diseases"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01967001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01967001\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01967001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T07:19:09Z","timestamp":1626247149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01967001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,4]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1991,4]]}},"alternative-id":["BF01967001"],"URL":"https:\/\/doi.org\/10.1007\/bf01967001","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,4]]}}}